On August 23, the event “Development Trends of Medical Devices under the New Landscape and Response Strategies: Discovering the Unicorns of Southeast University” was successfully held at the Nanjing Institute of Advanced Life and Health, Chinese Academy of Sciences.
On August 23, the event “Discovering the Eastern Unicorn: Development Trends and Response Strategies for the Medical Device Industry under the New Landscape” was successfully held at the Nanjing Institute of Advanced Life and Health, Chinese Academy of Sciences. More than 50 elites from the medical device industry gathered to explore how, amid intense market competition, professionals in the sector can transform competitive pressure into momentum and enhance corporate competitiveness through innovation and service differentiation.

Zhou Wenhai, Vice President of the Southeast University Nanjing Alumni Association and former Level-II Inspector at the Nanjing Municipal Science and Technology Bureau, delivered the opening address. He encouraged leveraging alumni resources, enhancing connections among alumni, and promoting the exchange of knowledge and experience. Through the “Discovering SEU Unicorns” initiative, he aimed to build an innovation service system featuring vertical integration, sectoral synergy, and demonstration by exemplary cases, thereby supporting the high-quality development of alumni enterprises and jointly advancing the development of China’s medical device industry.

During the first half of the event, Yan Peng’an, General Manager of the Third Investment Department at Nanjing Innovation Investment Group, provided an in-depth analysis of the current status and trends in the medical device industry. Yan Peng’an stated that China’s medical device industry has experienced rapid growth in recent years, gradually building its competitiveness in the global market and moving toward a more mature and sustainable development path. Amidst such intense domestic competition, the only way to break through is to actively explore innovations in service models and accelerate the process of “going global.”

Dang Xue, Secretary-General of the Cross-Border Trade Professional Committee under the Jiangsu Regional Cooperation and Exchange Association; Wang Yaomin, Founder of the Shanghai Ferryman Supply Chain Club; and Yan Shixian, Partner and Vice President of Sales at Dingtuo Technology Co., Ltd., served as three guest speakers who provided detailed insights on strategies for the medical device industry and layout in new market segments. They emphasized that the medical device industry must implement refined operations, ensure compliant international expansion, adopt multi-channel global market entry strategies, and achieve coordination and unified management across independent links or processes within the supply chain. These measures aim to strengthen industry collaboration and enhance corporate profitability.

In the second half of the event, Yao Zhibiao, Advisor to the Nanjing Alumni Association of Southeast University, delivered a presentation titled “Alumni Economy Sharing: Stimulating New Momentum for Innovation and Collaboration.” He stated that the development of the alumni economy should not be confined to a single university; instead, alliances among universities should be fostered to leverage the innovative potential of their respective alumni economies, thereby better serving alumni-owned enterprises.

Huang Jie from the Department of Science and Technology Development at the Nanjing Advanced Institute for Life and Health, Chinese Academy of Sciences (CAS), introduced the institute. Director Huang stated that the institute boasts a team of scientific and technological talent led by academicians and leading scientists from CAS. It has established three key generic technology R&D and translation platforms focusing on novel vaccines, antibodies and molecules, and immunodiagnostics. These platforms comprise five specialized technical centers and multiple functional technical modules. The institute aims to provide technical service support to upstream and downstream enterprises in the biopharmaceutical industry through this event.

During the roadshow session, moderated by Zhu Haihua, Secretary-General of the Southeast University Alumni Association for the Pharmaceutical and Healthcare Industry, six outstanding medical device professionals shared insights on their companies’ specific projects. The on-site discussions were vigorous, with multiple project representatives engaging in exchanges with the Advanced Institute of Research on topics such as project technologies and requirements, and expressing their intention to further deepen cooperation in the future.

Zhongke Nengda Electronics Co., Ltd. Dai Xinqi

Ruichong Medical Technology Co., Ltd. Liu Xiaoqun

Huichuang Xingmei Biotechnology Co., Ltd. Dong Hailin

Baifu Laser Technology Co., Ltd. Liao Ziyan

Raycool Medical, Zhang Shiyu

Xinchen Health Wang Xin
This event was hosted by the Management Committee of Qilin Science and Technology Innovation Park, the Nanjing Advanced Institute for Life and Health of the Chinese Academy of Sciences, and the Southeast University Alumni Association in Nanjing; co-organized by the Medical Branch of the Southeast University Alumni Association in Nanjing, the Southeast University Alumni Association for the Pharmaceutical and Healthcare Industry, the Nanjing Bio-pharmaceutical Industry Innovation and Translation Center, Magike.com, and the Xinjiekou Sub-branch of Industrial and Commercial Bank of China; and undertaken by Ruanlian (Nanjing) Medical Technology Co., Ltd.
Project 1: Externally Powered Endoscopic Capsule
Project Introduction:A Disruptive and Innovative Product from USTC: Addressing the Challenges of Bulky Size, High Cost, and Short Operational Duration in Battery-Powered Capsule Endoscopes. A Proof-of-Concept Prototype Has Been Completed, Achieving Miniaturized, Low-Cost Operation at a 2W Transmission Power, with Strong Potential to Become the Mainstream Solution for Painless Gastrointestinal Endoscopy.
Project 2:Cross-linked Sodium Hyaluronate Filler Containing Polyhydroxyalkanoate (PHA) Microspheres for Medical Use
Project Introduction:The new generation of regenerative injection is the world’s first composite microsphere-based regenerative injection prepared using polyhydroxyalkanoate (PHA) microspheres derived from synthetic biology materials and fabricated via a dual cross-linking technology combining microspheres with hyaluronic acid. It features superior microsphere dispersion, a more uniform and stable colloidal structure, consistent physical properties during degradation, and controllable degradation time, offering enhanced safety and supportive effects compared to similar products.
Project 3: R&D and Industrialization of High-End Medical Aesthetic Laser Devices
Project Introduction:Suzhou Baifu Laser is a high-tech enterprise dedicated to the research and development, production, and sales of high-end optoelectronic medical devices. The company boasts an experienced R&D team and independently developed core components, achieving domestic breakthroughs in the localization of certain equipment. It has independently developed a series of laser products, including Q-switched Nd:YAG lasers, 1064nm long-pulse lasers, 755nm alexandrite long-pulse lasers, 2940nm erbium lasers, and 1064&532nm picosecond lasers. The relevant technical indicators have reached a leading level in China.
Project 4: Digital Pain Rehabilitation Solutions
Project Introduction:Currently, common clinical pain management approaches typically begin with foundational therapies, followed by targeted and precise interventions based on the localization and characterization of the patient’s pain. These interventions primarily include pharmacological treatment, minimally invasive procedures, and combination therapies. Since the etiology of pain is often multifactorial, multimodal combination therapy frequently yields superior outcomes compared to monotherapy, achieving a synergistic effect where “1+1>2.” Based on the theoretical framework of holistic pain management encompassing “sensation–cognition–emotion–behavior,” this study introduces an innovative non-pharmacological therapeutic approach for patients with neuropathic pain in pain medicine departments. This method can, to a certain extent, alleviate pain, reduce nociceptive stimulation, mitigate negative emotional responses to pain, and improve patients’ quality of life.
Project 5: A New Chain Model for Pet Hospitals Based on the Core Industry Chain—The “Pagoda” of Pet Hospitals
Project Introduction:The pet market is currently experiencing rapid growth with immense development potential. However, players in the veterinary medical device sector and veterinary hospitals within this industry chain struggle to scale up and strengthen their market position. Leveraging robust supply chains and R&D capabilities from the human healthcare sector, this project can rapidly develop and manufacture tailored solutions—including veterinary medical devices, consumables, and pharmaceuticals—based on specific surgical scenarios, thereby reducing procurement costs for veterinary hospitals. Furthermore, it aims to establish a three-tier model of benchmark veterinary facilities: community clinics, central hospitals, and flagship hospitals, which will lower the barriers to construction and management for veterinary practices. As various business units of Ruichong Group progressively advance these initiatives, they are poised to reshape the veterinary industry.
Module 6: Auscultation-Based Fetal Monitoring Technology
Project Introduction:Fetaphon is the first auscultation-based fetal monitor to receive medical device registration certification. Utilizing an auscultatory method for phonocardiography, Fetaphon differs from traditional Doppler ultrasound devices by emitting no energy waves and passively capturing fetal heart sounds only. Compared with Doppler fetal monitoring instruments, it offers exceptionally high safety performance. It is the first fetal monitor based on the auscultatory principle to obtain medical device certification. Its in-hospital and out-of-hospital monitoring performance has been excellent at institutions such as Jiangsu Provincial Hospital of Maternity and Child Health Care, Nanjing Drum Tower Hospital, The Second Affiliated Hospital of Soochow University, and Changzhou Maternal and Child Health Care Hospital, earning consistent recognition from healthcare professionals.
As an affiliated institution of the National Natural Science Foundation of China, a Jiangsu Provincial New R&D Institution, and a Jiangsu Provincial Postdoctoral Innovation Practice Base, the Advanced Research Institute (ARI) is dedicated to the translation of scientific achievements. It focuses on key theoretical and technological innovations and product development in areas such as novel vaccines, antibodies, and molecular diagnostics. The ARI strives to establish a national-level hub for original innovation and achievement translation in life and health sciences, providing robust scientific and technological support for technological innovation and the transformation and upgrading of industrial structures in China’s life and health sector.The ARI boasts a team of scientific and technological talents led by academicians and leading scientists from the Chinese Academy of Sciences. Aligned with its R&D directions, the ARI has established three major platforms for the research, development, and translation of key generic technologies: novel vaccines, antibodies and molecules, and immunodiagnostics. These platforms comprise five specialized technical centers and multiple functional technical modules, providing essential technical support for platform development.
The Discovery of Southeast University Unicorn Competition is a selection contest guided by Southeast University, hosted by the General Alumni Association of Southeast University, and organized by the Nanjing Alumni Association of Southeast University. It aims to identify high-growth technology startups with broad influence among Southeast University alumni worldwide. Launched in 2019 and held annually, it has become one of the largest and longest-running alumni entrepreneurship competitions among Chinese universities. The competition seeks to build a comprehensive platform for entrepreneurial alumni to showcase their ventures, exchange ideas, secure financing, and achieve growth, while also providing a matchmaking platform for individuals and organizations from all sectors of society who are willing to mentor, support, and invest in innovative projects, thereby fostering the development of new quality productive forces.
Inquiry Regarding the Discovery of Dongda Unicorn Competition
Registration/Partnership Inquiries: Mr./Ms. Zhong
Contact Number: 15960317626 (also for WeChat)